IGI grants 209,938 stock options to employees

International Gemological Institute Limited has announced the grant of 209,938 stock options to eligible employees under its IGI Employee Stock Option Plan 2024. The decision was approved by the company's Nomination and Remuneration Committee during its meeting held on May 20, 2026.

The options granted are exercisable into not more than 209,938 fully paid-up equity shares. Each equity share carries a face value of ₹2. The pricing formula for these options was determined by the Nomination and Remuneration Committee and is in line with the IGI ESOP Plan 2024.

Details of the Grant

The scheme is compliant with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The specific terms regarding the time within which the options may be exercised are detailed in the grant letters issued to the employees and as per the IGI ESOP Plan 2024.

Key Metrics

Particulars Details Options Granted 209,938 Shares Covered 209,938 equity shares Face Value ₹2 per share Pricing Formula As determined by NRC

The company stated that significant terms of the options are mentioned in the respective grant letters. Information regarding the exercise of options, money realized, and diluted earnings per share is not applicable at this stage.

International Gemological Institute Limited has announced that the audio recording of its earnings call is now available. The call was held on Wednesday, May 20, 2026, to discuss the company's financial performance for the quarter and financial year ended March 31, 2026.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided the recording to ensure stakeholders have access to the detailed discussion regarding its recent financial results.

Accessing the Recording

The audio recording can be accessed through the dedicated investor relations section of the company's website. Stakeholders and interested investors can listen to the discussion to gain insights into the financial figures and operational highlights presented by the management.

The following table provides the key details regarding the earnings call disclosure:

Event Details Information Event Earnings Call Audio Recording Release Date of Call May 20, 2026 Financial Period Quarter and Year Ended March 31, 2026 Availability Company Website

This intimation has been formally communicated to the BSE Limited and the National Stock Exchange of India Limited. The company has confirmed that the recording is hosted on its website for public access.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.